Zeo ScientifiX files 10-KT for 2026 transition period
- Fiscal year end changed from October 31 to June 30
- Launched two IRB-approved clinical studies
- Sold Exotropin interests on April 7, 2026
Every EDGAR filing for Zeo ScientifiX, Inc. (ZEOX), newest first, with AI summaries and stories.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Greyt Ventures, LLC (amended)
Greyt Ventures, LLC, filed by
Ownership stake disclosure by Ian T Bothwell (amended)
Ian T Bothwell, filed by
Ownership stake disclosure by George Craig Shapiro (amended)
George Craig Shapiro, filed by
Wendy Grey, insider filing for ZEOX
Wendy Grey, reporting ยท Greyt Ventures, LLC, reporting
Ownership stake disclosure by Ian T Bothwell (amended)
Ian T Bothwell, filed by
Ownership stake disclosure by Greyt Ventures, LLC (amended)
Greyt Ventures, LLC, filed by
John David Kisiday, new insider at ZEOX
John David Kisiday, reporting
Ian T Bothwell, insider filing for ZEOX
Ian T Bothwell, reporting